Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic

Tongtong Liu1, Yingjie Guan2, Juan Li1

  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences.

Medicine
|November 21, 2020
PubMed

Insights

This systematic review investigates if hypothyroidism independently predicts cardiovascular risk in chronic kidney disease (CKD) patients. Findings will inform clinical management of CKD with hypothyroidism.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) is the leading cause of mortality in chronic kidney disease (CKD) patients.
  • Hypothyroidism is a common complication in CKD patients and is known to increase cardiovascular risk.
  • The independent predictive role of hypothyroidism for cardiovascular risk in CKD patients requires further investigation.

Purpose of the Study:

  • To systematically review and meta-analyze existing studies to determine if hypothyroidism is an independent predictor of cardiovascular risk in patients with CKD.
  • To provide robust evidence on the association between hypothyroidism and cardiovascular outcomes in the CKD population.

Main Methods:

  • A comprehensive literature search will be conducted across multiple databases including PubMed, Embase, Web of Science, CNKI, CBM, and Wanfang.
  • Eligible study designs include cross-sectional, case-control, and cohort studies examining the link between hypothyroidism and cardiovascular risk in CKD patients.
  • Data extraction and quality assessment will be performed independently by two researchers, with data synthesis using STATA and TSA software.

Main Results:

  • The systematic review will evaluate the association by analyzing the incidence of cardiovascular events in CKD individuals with hypothyroidism.
  • Quantification of the risk conferred by hypothyroidism on cardiovascular events in CKD patients will be performed.

Conclusions:

  • This study aims to provide significant evidence regarding the correlation between hypothyroidism and cardiovascular risk in CKD patients.
  • The findings are expected to contribute to improved clinical management and practice for the CKD population, particularly those with co-existing hypothyroidism.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
378
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
171
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
225
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
373
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
641
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
81